RPT2B Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Nomenclature and Identification Challenges

Antibodies are often named based on their target antigens, clonal origins, or proprietary designations. For example:

  • RBD-targeting antibodies (e.g., B38, COV2-2196) neutralize SARS-CoV-2 by binding its receptor-binding domain .

  • Bispecific antibodies (e.g., faricimab, glofitamab) employ CrossMab technology to engage dual targets .

The absence of "RPT2B" in databases like CiteAb, RRID, or the Antibody Society’s therapeutic antibody list suggests it may be a hypothetical, proprietary, or misidentified compound . Researchers should verify nomenclature against standardized registries or confirm its existence in institutional repositories.

Methodologies for Antibody Discovery and Validation

Emerging techniques address challenges in antibody characterization:

LIBRA-seq

Developed by Vanderbilt University, this platform enables high-throughput identification of broadly neutralizing antibodies by linking B-cell receptor sequences to antigen specificity . Applications include:

  • Isolation of ultrapotent monoclonal antibodies against SARS-CoV-2 variants .

  • Discovery of cross-reactive antibodies targeting HIV, HCV, and SARS-CoV-2 .

YCharOS and RRID

  • YCharOS validates antibody specificity using knockout (KO) cell lines, revealing that ~12 publications per protein target use non-specific antibodies .

  • RRID assigns unique identifiers for reagents, though lot-to-lot variability remains a challenge .

Therapeutic Antibody Development Challenges

The antibody characterization crisis highlights systemic issues:

  1. High attrition rates: ~50–75% of antibodies fail in functional assays due to poor specificity or affinity .

  2. Lot variability: Recombinant antibodies often outperform monoclonal/polyclonal ones but require stringent quality control .

  3. Data transparency: Initiatives like CiteAb and SciScore aim to improve reproducibility by linking reagents to published validation data .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
RPT2B antibody; At2g20140 antibody; T2G17.6 antibody; 26S proteasome regulatory subunit 4 homolog B antibody; 26S proteasome AAA-ATPase subunit RPT2b antibody; 26S proteasome subunit 4 homolog B antibody; Regulatory particle triple-A ATPase subunit 2b antibody
Target Names
RPT2B
Uniprot No.

Target Background

Function
The 26S protease is involved in the ATP-dependent degradation of ubiquitinated proteins. The regulatory (or ATPase) complex confers ATP dependency and substrate specificity to the 26S complex. RPT2B acts redundantly with RPT2A in the regulation of gametogenesis. Together with RPT2A, it plays a critical role in 26S proteasome assembly.
Gene References Into Functions
  1. RPT2 is essential for assembly of the plant 26S proteasome and RPT2a and b isoforms are functionally equivalent. [RPT2b] PMID: 22158466
  2. RPT2a and RPT2b proteins appear to be functionally equivalent in the root apical meristem, but RPT2b is dispensable for meristem function. [RPT2b] PMID: 21784786
Database Links

KEGG: ath:AT2G20140

STRING: 3702.AT2G20140.1

UniGene: At.13496

Protein Families
AAA ATPase family
Subcellular Location
Cytoplasm. Nucleus.
Tissue Specificity
Preferentially expressed in the root and shoot apical meristem.

Q&A

What is RPT2B and what are its cellular functions?

RPT2B, also known as 26S proteasome regulatory subunit 4 homologB, is a crucial component of the 19S regulatory particle within the 26S proteasome complex. It functions as an ATPase that contributes to ATP-dependent unfolding of substrate proteins and their translocation into the 20S core particle for degradation. In Arabidopsis thaliana, this protein is encoded by the AT2G20140 gene . RPT2B plays vital roles in maintaining protein homeostasis across various cellular processes, including stress responses, cell cycle regulation, and developmental pathways. The protein exhibits high conservation across different plant species, indicating its fundamental importance in eukaryotic cellular function. Recent studies have emphasized its role in coordinating protein quality control mechanisms, particularly under environmental stress conditions.

What is the relationship between RPT2A and RPT2B proteins?

RPT2A and RPT2B are paralogous proteins with highly similar sequences and function. According to available data, the synthetic peptide used for RPT2B antibody immunization shares 100% sequence homology with the corresponding region in RPT2A (AT4G29040) . This high sequence similarity explains why antibodies raised against one protein often recognize both. For instance, the anti-RPT2a antibody also detects the RPT2B protein in experimental applications . Despite their similarities, the two proteins may have evolved distinct functions or expression patterns in certain tissues or developmental stages. Researchers investigating either protein should be aware of this cross-reactivity when designing experiments and interpreting results, especially in studies aiming to distinguish the specific roles of these two proteins.

What is the expected molecular weight of RPT2B in Western blot analysis?

In SDS-PAGE and Western blot applications, RPT2B has an expected theoretical molecular weight of approximately 49.4 kDa, while its apparent molecular weight typically appears around 50 kDa . This slight discrepancy between theoretical and observed molecular weights is common for many proteins due to factors such as post-translational modifications, specific amino acid compositions affecting SDS binding, or conformational properties that influence migration in polyacrylamide gels. When interpreting Western blot results, researchers should consider this expected migration pattern and be aware that variations in experimental conditions, such as gel percentage or buffer systems, might slightly affect the apparent molecular weight.

What plant species show cross-reactivity with RPT2B antibodies?

The high conservation of proteasome components across plant lineages results in extensive cross-reactivity of RPT2B antibodies. Based on available data, RPT2B antibodies have demonstrated reactivity with proteins from numerous plant species including Arabidopsis thaliana, Brassica rapa, Brassica napus, Populus trichocarpa, Glycine max, Gossypium raimondii, Medicago truncatula, Cucumis sativus, Vitis vinifera, Nicotiana tabacum, Solanum lycopersicum, Spinacia oleracea, Solanum tuberosum, Zea mays, Sorghum bicolor, Setaria viridis, Panicum virgatum, Physcomitrium patens, Chlamydomonas reinhardtii, Triticum aestivum, and Hordeum vulgare . This broad cross-reactivity makes RPT2B antibodies valuable tools for comparative studies across diverse plant species, enabling researchers to investigate proteasome function across evolutionary lineages and in non-model plant systems.

What are the recommended storage conditions for RPT2B antibodies?

For optimal stability and performance, RPT2B antibodies should be stored according to specific conditions based on their formulation. Lyophilized antibodies should be stored at -20°C for short-term (months) or -80°C for long-term storage (years) . After reconstitution, it is strongly recommended to make small aliquots to avoid repeated freeze-thaw cycles that can degrade antibody quality and reduce specificity and sensitivity. When thawing aliquots for use, ensure complete thawing at cool temperatures and avoid multiple freeze-thaw cycles. The manufacturer's recommendations typically specify using a manual defrost freezer to prevent damage that might occur during automatic defrost cycles. The antibody is shipped at 4°C, and upon receipt, it should be stored immediately at the recommended temperature to maintain its activity .

What are the optimal Western blot conditions for RPT2B antibody?

For optimal Western blot results with RPT2B antibody, the following protocol is recommended: Separate proteins using standard SDS-PAGE, preferably using 10-12% acrylamide gels for optimal resolution of proteins in the 50 kDa range. Transfer proteins to nitrocellulose membrane (preferred over PVDF for this application). Block the membrane with 10% non-fat milk to minimize background signal . Dilute primary RPT2B antibody at 1:3000 in appropriate blocking buffer (typically 5% milk or BSA in TBST) . Incubate the membrane with primary antibody solution at 4°C overnight or at room temperature for 2 hours with gentle agitation. Wash the membrane thoroughly with TBST buffer (at least 3-5 washes for 5 minutes each). Apply HRP-conjugated secondary antibody (anti-rabbit IgG) at the manufacturer's recommended dilution. Develop using sensitive chemiluminescence detection reagents. This protocol has been optimized to provide specific detection of RPT2B while minimizing background and cross-reactivity issues.

How should RPT2B antibody be reconstituted for maximum stability and performance?

For optimal reconstitution of lyophilized RPT2B antibody, add 50 μl of sterile water directly to the lyophilized powder . Before opening the vial, briefly centrifuge to ensure that all material is at the bottom of the tube, preventing loss of antibody that might adhere to the cap or sides . After adding water, gently rotate or tap the tube to ensure complete dissolution, but avoid vigorous shaking or vortexing which can damage antibody molecules. Allow the solution to sit for 5-10 minutes at room temperature to ensure complete rehydration. After reconstitution, aliquot the antibody into small volumes (5-10 μl) in sterile microcentrifuge tubes to minimize freeze-thaw cycles. Label each aliquot with antibody details, date of reconstitution, and concentration. Store aliquots at -20°C for short-term use or -80°C for long-term preservation. When using the antibody, thaw aliquots completely before use and keep them on ice during experimental procedures to maintain antibody stability.

What controls should be included when using RPT2B antibody in experiments?

Rigorous experimental design requires appropriate controls when using RPT2B antibody to ensure reliable interpretation of results. The following controls should be included in experimental protocols:

Control TypeDescriptionPurpose
Positive ControlWild-type plant tissue samples (e.g., Arabidopsis leaf extract)Confirms antibody activity and establishes expected band pattern
Negative Controlrpt2b mutant/knockdown samples when availableValidates specificity by showing reduced/absent signal
Loading ControlDetection of housekeeping proteins (actin, tubulin, GAPDH)Normalizes for variations in protein loading and transfer efficiency
Primary Antibody OmissionMembrane section treated identically but without primary antibodyIdentifies non-specific binding of secondary antibody
Peptide CompetitionPre-incubation of antibody with immunizing peptideDemonstrates specificity of the observed signal
Technical ReplicatesMultiple lanes of the same sampleAssesses reproducibility within experiment
Biological ReplicatesIndependent biological samplesConfirms biological relevance of observations

Including these controls systematically helps validate experimental findings and troubleshoot technical issues that may arise during immunodetection procedures .

How can I validate the specificity of RPT2B antibody in my experimental system?

Validating antibody specificity is crucial for ensuring reliable experimental results. For RPT2B antibody, a comprehensive validation strategy should include multiple approaches:

  • Genetic validation: Compare protein detection in wild-type versus rpt2b knockout/knockdown lines. A specific antibody will show significantly reduced or absent signal in mutant samples.

  • Peptide competition assay: Pre-incubate the antibody with excess immunizing peptide before application to samples. Specific signals should be significantly reduced or eliminated.

  • Western blot analysis: Verify that the detected protein band appears at the expected molecular weight (~50 kDa) and shows consistent pattern across different sample preparations.

  • Immunoprecipitation followed by mass spectrometry: Confirm that the antibody pulls down RPT2B protein by identifying peptides through mass spectrometry.

  • Comparison with orthogonal methods: Correlate protein detection with transcript levels measured by RT-qPCR or with tagged versions of the protein.

  • Cross-reactivity assessment: Test the antibody against recombinant RPT2A and RPT2B proteins to determine relative affinities and potential cross-reactivity issues .

These validation steps should be documented and included in publications to support the reliability of experimental findings based on RPT2B antibody applications.

What sample preparation methods are recommended for optimal detection of proteasome components?

Effective detection of proteasome components like RPT2B requires careful sample preparation to preserve protein integrity and complex associations. The following protocol is recommended:

  • Tissue collection: Harvest fresh plant tissue and immediately flash-freeze in liquid nitrogen to prevent protein degradation.

  • Extraction buffer: Use a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10% glycerol, 1 mM DTT, and protease inhibitor cocktail. For studies requiring active proteasome, avoid denaturation.

  • Tissue disruption: Grind frozen tissue to a fine powder in liquid nitrogen using a mortar and pestle. Add cold extraction buffer (2-3 mL per gram of tissue) and continue grinding until homogeneous.

  • Homogenization: Transfer the homogenate to microcentrifuge tubes and further homogenize with brief sonication (3 × 10s pulses) while keeping samples cold.

  • Clarification: Centrifuge homogenates at 12,000-15,000 × g for 15 minutes at 4°C to remove cell debris and insoluble material.

  • Protein quantification: Determine protein concentration using Bradford or BCA assay, adjusting samples to equal concentrations.

  • Sample preparation for SDS-PAGE: Mix samples with Laemmli buffer (final concentrations: 2% SDS, 10% glycerol, 5% β-mercaptoethanol, 0.002% bromophenol blue, 62.5 mM Tris-HCl, pH 6.8), heat at 95°C for 5 minutes.

  • Loading: Load 20-30 μg total protein per lane for optimal detection of RPT2B in most plant tissues.

This careful preparation ensures reliable and reproducible detection of proteasome components in experimental systems .

Why might I observe multiple bands when using RPT2B antibody in Western blot?

The presence of multiple bands in Western blots with RPT2B antibody can stem from several biological and technical factors that researchers should systematically evaluate:

  • Cross-reactivity with RPT2A: The most likely explanation is detection of both RPT2A and RPT2B proteins due to their high sequence homology. The anti-RPT2B antibody shares 100% sequence homology with regions in RPT2A , leading to detection of both paralogs.

  • Post-translational modifications: Phosphorylation, ubiquitination, or other modifications can generate forms with shifted electrophoretic mobility. Proteasome components are often regulated by such modifications.

  • Proteolytic degradation: Incomplete protease inhibition during sample preparation may result in partial degradation products, especially problematic with regulatory proteins.

  • Alternative splicing: Potential splice variants of RPT2B could generate protein isoforms with different molecular weights.

  • Non-specific binding: Insufficient blocking or excessive antibody concentration may lead to non-specific binding to other proteins.

To address these issues, researchers should optimize blocking conditions (10% non-fat milk is recommended ), adjust antibody dilutions, include appropriate controls such as rpt2a or rpt2b mutants when available, and ensure consistent sample preparation with effective protease inhibition.

How can I distinguish between RPT2A and RPT2B signals in my experiments?

Distinguishing between RPT2A and RPT2B signals presents a significant challenge due to their high sequence similarity and antibody cross-reactivity. Researchers can implement several strategies to differentiate between these paralogs:

  • Genetic approach: Utilize rpt2a or rpt2b knockout/knockdown lines from Arabidopsis or other systems where the specific absence of one protein can help identify the corresponding band.

  • Recombinant protein standards: Run purified recombinant RPT2A and RPT2B proteins alongside experimental samples to establish exact migration patterns for each protein.

  • Isoform-specific antibodies: If available, use antibodies raised against unique regions that differ between the two proteins, though these may be difficult to generate due to high sequence conservation.

  • Immunoprecipitation with gene-specific antibodies: Though challenging, antibodies with slight preferences for one paralog over the other might be used for immunoprecipitation followed by more sensitive detection methods.

  • Mass spectrometry: After gel separation, excise bands of interest and perform mass spectrometry to identify unique peptides that can differentiate between RPT2A and RPT2B.

  • Expression pattern analysis: In some tissues or under specific conditions, one paralog may be predominantly expressed, allowing contextual identification of bands.

These approaches, often used in combination, can help researchers attribute observed signals to the specific protein of interest in their experimental system .

What strategies can improve weak signal detection when using RPT2B antibody?

When confronted with weak signal issues in RPT2B detection, researchers can implement several optimization strategies:

  • Protein loading optimization: Increase total protein loading to 30-50 μg per lane to enhance detection of low-abundance proteins. This is particularly important for tissues with naturally low RPT2B expression.

  • Antibody concentration adjustment: Try higher concentrations of primary antibody (e.g., 1:1000 instead of the standard 1:3000) while monitoring for increased background.

  • Incubation optimization: Extend primary antibody incubation to overnight at 4°C, which often improves binding efficiency while maintaining specificity.

  • Enhanced detection systems: Use more sensitive chemiluminescence substrates such as enhanced ECL or femto-sensitivity reagents that offer 10-100× greater detection sensitivity.

  • Signal amplification: Consider biotin-streptavidin amplification systems or tyramide signal amplification protocols for extremely low-abundance targets.

  • Membrane optimization: Nitrocellulose membranes are specifically recommended for RPT2B detection over PVDF membranes .

  • Transfer efficiency: For proteins around 50 kDa, optimize transfer time and voltage for maximum efficiency without protein pass-through.

  • Blocking optimization: While 10% milk is recommended , testing alternative blocking agents (BSA, commercial blockers) may improve results for specific sample types.

These adjustments, systematically tested, can significantly improve signal detection while maintaining experimental specificity.

How should I quantify and normalize RPT2B levels in comparative experiments?

Reliable quantification and normalization of RPT2B levels in comparative studies requires rigorous methodology:

  • Digital image acquisition: Capture Western blot images using a digital imaging system with a documented linear dynamic range. Avoid film exposure which often has non-linear response characteristics.

  • Dynamic range verification: Ensure signal intensities fall within the linear range of detection by running a dilution series of a reference sample.

  • Normalization strategy options:

    • Housekeeping protein normalization: Normalize RPT2B signals to stable reference proteins (actin, tubulin, GAPDH) that remain constant across experimental conditions.

    • Total protein normalization: Use total protein staining methods (Ponceau S, SYPRO Ruby, stain-free technology) which often provide more reliable normalization across diverse conditions than single housekeeping proteins.

  • Technical considerations:

    • Include multiple technical replicates (typically 3) of each sample.

    • Process biological replicates (n ≥ 3) across independent experiments.

    • Use appropriate statistical tests (t-test for two-group comparisons, ANOVA for multiple groups) to determine significant differences.

  • Densitometry analysis:

    • Use specialized software (ImageJ, Image Lab, etc.) with consistent background subtraction methods.

    • Define regions of interest (ROIs) consistently across all lanes.

    • Report normalized values as relative changes rather than absolute values.

This systematic approach to quantification reduces technical variability and ensures that observed differences in RPT2B levels genuinely reflect biological changes rather than methodological artifacts .

How do experimental conditions affect RPT2B detection and interpretation?

Various experimental conditions can significantly impact RPT2B detection and data interpretation:

  • Sample preparation effects:

    • Temperature: Excessive heating during sample preparation can cause protein aggregation or degradation affecting migration patterns.

    • Detergent types and concentrations: Different detergents may extract RPT2B with varying efficiency, especially when associated with membranes or protein complexes.

    • Buffer composition: Salt concentration and pH affect protein solubilization and epitope accessibility.

  • Gel system considerations:

    • Gel percentage significantly impacts resolution around 50 kDa where RPT2B migrates.

    • Running conditions (voltage, temperature, buffer composition) affect band sharpness and resolution.

  • Transfer variables:

    • Transfer method (wet vs. semi-dry) influences efficiency for 50 kDa proteins.

    • Transfer duration and voltage require optimization for maximal transfer without protein loss.

  • Antibody performance factors:

    • Temperature of antibody incubation affects binding kinetics and specificity.

    • Antibody lot-to-lot variations can occur and should be monitored.

    • Dilution buffer composition impacts background and specific signal intensity.

  • Detection method considerations:

    • Chemiluminescence vs. fluorescence detection systems offer different sensitivity and dynamic range.

    • Exposure time optimization is critical for accurate quantification.

To ensure consistent and interpretable results, researchers should standardize these conditions across experiments and document all relevant parameters in publications to support reproducibility .

How can RPT2B antibody be used to study proteasome assembly dynamics?

RPT2B antibody offers valuable applications for investigating proteasome assembly dynamics through several sophisticated approaches:

  • Co-immunoprecipitation studies: RPT2B antibody can be used to pull down the protein along with its interacting partners. Analysis of co-precipitated proteins by Western blotting or mass spectrometry can reveal assembly intermediates and regulatory factors that interact with RPT2B during proteasome biogenesis.

  • Sucrose gradient fractionation: Cell or tissue lysates can be separated on sucrose gradients to isolate different proteasome assembly intermediates based on their sedimentation properties. Western blotting with RPT2B antibody across gradient fractions can track the incorporation of RPT2B into assembly intermediates versus mature proteasomes.

  • Blue native PAGE: Non-denaturing gel electrophoresis combined with Western blotting using RPT2B antibody allows visualization of intact proteasome complexes and sub-complexes, providing insights into the assembly state of the proteasome under different conditions.

  • Immunofluorescence microscopy: RPT2B antibody can be used for immunofluorescence to visualize the subcellular localization of RPT2B during different stages of proteasome assembly, particularly in response to cellular stresses that may affect proteasome biogenesis.

  • Pulse-chase experiments: Combined with metabolic labeling, RPT2B antibody can be used to immunoprecipitate newly synthesized and mature forms of the protein, allowing researchers to track the kinetics of RPT2B incorporation into proteasome complexes.

These approaches provide comprehensive insights into how proteasomes are assembled, maintained, and regulated in different cellular contexts .

What techniques can be combined with RPT2B immunodetection for studying protein degradation pathways?

To gain comprehensive understanding of protein degradation pathways, RPT2B immunodetection can be integrated with multiple complementary techniques:

  • Proteasome activity assays: Correlate RPT2B levels with functional proteasome activity using fluorogenic peptide substrates (e.g., Suc-LLVY-AMC for chymotrypsin-like activity). This correlation helps establish whether changes in RPT2B levels translate to functional impacts on proteolysis.

  • Ubiquitination profiling: Combine RPT2B detection with ubiquitin antibodies to study relationships between proteasome composition and global ubiquitination patterns. This approach can reveal whether alterations in RPT2B affect substrate recognition and processing.

  • Proximity-dependent biotin identification (BioID): Fusing BioID to RPT2B allows identification of proteins that come into close proximity with RPT2B in living cells, potentially revealing novel substrates or regulatory partners.

  • Protein half-life measurements: Use cycloheximide chase experiments or pulse-chase labeling to determine whether alterations in RPT2B levels affect the degradation rates of specific substrate proteins.

  • Quantitative proteomics: Stable isotope labeling (SILAC) or tandem mass tag (TMT) approaches can quantify global changes in protein abundance when RPT2B function is altered, identifying potential substrate classes.

  • Cryo-electron microscopy: Structural studies of proteasome complexes can be correlated with RPT2B immunodetection to understand how RPT2B positioning affects proteasome structure and function.

  • Single-cell analysis: Combine RPT2B immunostaining with measurements of proteasome activity in individual cells to understand cell-to-cell variation in proteasome function.

These integrated approaches provide a systems-level understanding of how RPT2B contributes to cellular protein degradation mechanisms .

How can RPT2B antibody be used in studies examining proteasome stress responses?

RPT2B antibody serves as a powerful tool for investigating proteasome stress responses through several experimental approaches:

  • Stress response monitoring: Track changes in RPT2B protein levels, post-translational modifications, or subcellular localization in response to various cellular stressors (heat shock, oxidative stress, ER stress, pathogen infection). Western blot analysis using RPT2B antibody can reveal how these stressors affect proteasome composition.

  • Proteasome inhibitor studies: Examine how pharmacological inhibition of the proteasome (using MG132, bortezomib, etc.) affects RPT2B levels and incorporation into proteasome complexes. This approach helps understand compensatory mechanisms that cells employ when proteasome function is compromised.

  • Genetic perturbation analysis: Compare RPT2B protein expression and localization in wild-type plants versus mutants with defects in protein quality control pathways (e.g., hsf, ubiquitin ligase mutants). This comparison helps place RPT2B in the broader context of cellular stress response networks.

  • Time-course experiments: Monitor dynamic changes in RPT2B during stress application and recovery phases to understand temporal aspects of proteasome regulation during stress adaptation.

  • Tissue-specific responses: Use immunohistochemistry with RPT2B antibody to examine tissue-specific variations in proteasome stress responses, particularly in complex multicellular organisms.

  • Cross-species comparative analysis: Leverage the broad cross-reactivity of RPT2B antibodies across plant species to compare evolutionary conservation of proteasome stress responses between different plant lineages.

These applications provide insights into how cells modulate proteasome composition and function to maintain proteostasis under challenging conditions .

What are the considerations for using RPT2B antibody in immunoprecipitation experiments?

Successful immunoprecipitation (IP) experiments with RPT2B antibody require careful attention to several critical factors:

  • Antibody suitability: Verify whether the specific RPT2B antibody formulation is validated for immunoprecipitation applications, as not all antibodies that work in Western blot will perform well in IP.

  • Buffer optimization:

    • Use gentle, non-denaturing lysis buffers (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol, 0.1-0.5% NP-40) to preserve protein-protein interactions.

    • Include protease inhibitors to prevent degradation during the procedure.

    • Test different detergent types and concentrations that efficiently extract RPT2B without disrupting important interactions.

  • Experimental controls:

    • Include negative controls (non-immune serum or IgG from the same species as the RPT2B antibody).

    • Set aside input sample (typically 5-10% of starting material) to confirm protein presence.

    • When available, use rpt2b mutant samples as negative controls to validate specificity.

  • Technical considerations:

    • Pre-clear lysates with Protein A/G beads before adding specific antibody to reduce non-specific binding.

    • Optimize antibody amount and incubation time (typically 2-5 μg antibody per mg of total protein, incubated overnight at 4°C).

    • Wash stringency requires careful balance - sufficient to remove non-specific binders but not so stringent as to disrupt legitimate interactions.

  • Analysis approaches:

    • Western blot verification of immunoprecipitated material using the same or different RPT2B antibody.

    • Mass spectrometry analysis of co-immunoprecipitated proteins to identify interaction partners.

    • For co-IP studies, reciprocal experiments (IP with antibodies against suspected interaction partners) strengthen confidence in results.

These considerations help ensure successful immunoprecipitation experiments that yield reliable insights into RPT2B protein interactions and complex formation .

How can RPT2B antibody contribute to understanding evolutionary conservation of proteasome function?

The broad cross-reactivity of RPT2B antibodies across diverse plant species makes them valuable tools for evolutionary studies of proteasome function:

  • Comparative proteasome analysis: RPT2B antibody can detect the protein across numerous plant species including Arabidopsis, Brassica, Populus, Glycine, Solanum, Zea, and even evolutionary distant species like the moss Physcomitrium patens and the green alga Chlamydomonas reinhardtii . This broad reactivity enables direct comparison of proteasome composition across evolutionary diverse lineages.

  • Conservation of regulatory mechanisms: By examining RPT2B protein levels, modification states, and complex incorporation across species, researchers can determine which regulatory mechanisms controlling proteasome function are evolutionarily conserved versus lineage-specific.

  • Stress response conservation: Comparing RPT2B regulation during stress responses across multiple plant species can reveal whether proteasome adaptation to environmental challenges follows conserved patterns or has evolved divergent strategies.

  • Structure-function relationships: Combined with sequence analysis, RPT2B detection across species can help identify conserved domains that are critical for function versus regions that may have evolved species-specific roles.

  • Developmental regulation: Examining RPT2B expression during comparable developmental stages across different plant species can illuminate conserved versus divergent roles of the proteasome in plant development.

  • Proteasome complex stability: Comparing the stability and composition of proteasome complexes across species using RPT2B as a marker provides insights into evolutionary constraints on proteasome structure.

The extensive cross-reactivity of RPT2B antibodies with proteins from monocots, dicots, mosses, and green algae makes them particularly valuable for these evolutionary comparative studies .

Key considerations for successful application of RPT2B antibody in research

Success with RPT2B antibody in research applications depends on understanding several critical factors. First, researchers must account for the cross-reactivity between RPT2A and RPT2B due to their high sequence homology , which may require additional experimental controls to distinguish between these paralogs. Second, proper sample preparation is essential, with specific attention to protease inhibition and extraction conditions that preserve protein integrity. Third, storage and handling of the antibody significantly impact performance—following manufacturer recommendations for reconstitution, aliquoting to prevent freeze-thaw cycles, and maintaining proper temperature conditions are crucial . Fourth, validation through appropriate controls (including genetic mutants when available) strengthens confidence in experimental results. Finally, researchers should consider the broad cross-reactivity across plant species as both an advantage for comparative studies and a potential complication for specificity. By accounting for these factors, investigators can effectively leverage RPT2B antibodies to advance understanding of proteasome biology in plant systems.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.